{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:11:56Z","timestamp":1715386316307},"reference-count":33,"publisher":"Japan Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1507\/endocrj.ej22-0112","type":"journal-article","created":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T22:23:22Z","timestamp":1665181402000},"page":"59-67","source":"Crossref","is-referenced-by-count":0,"title":["Longitudinal clinical course in patients with 5\u03b1-reductase type 2 deficiency treated with testosterone and dihydrotestosterone during infancy and puberty"],"prefix":"10.1507","volume":"70","author":[{"given":"Daisuke","family":"Ariyasu","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Kawasaki Municipal Hospital, Kanagawa 210-0013, Japan"},{"name":"Division of Endocrinology and Metabolism, Tokyo Metropolitan Children\u2019s Medical Center, Tokyo 183-8561, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fusa","family":"Nagamatsu","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Tokyo Metropolitan Children\u2019s Medical Center, Tokyo 183-8561, Japan"},{"name":"Department of Pediatrics, Kumamoto University Hospital, Kumamoto 860-8556, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Aso","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Toho University Omori Medical Center, Tokyo 143-8541, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhisa","family":"Akiba","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Tokyo Metropolitan Children\u2019s Medical Center, Tokyo 183-8561, Japan"},{"name":"Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Tokyo Metropolitan Children\u2019s Medical Center, Tokyo 183-8561, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Wilson JD, Griffin JE, Russell DW (1993) Steroid 5 alpha-reductase 2 deficiency. Endocr Rev 14: 577\u2013593.","DOI":"10.1210\/edrv-14-5-577"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Mendonca BB, Batista RL, Domenice S, Costa EM, Arnhold IJ, et al. (2017) Reprint of \u201cSteroid 5\u03b1-reductase 2 deficiency\u201d. J Steroid Biochem Mol Biol 165: 95\u2013100.","DOI":"10.1016\/j.jsbmb.2016.11.006"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Lee PA, Nordenstr\u00f6m A, Houk CP, Ahmed SF, Auchus R, et al. (2016) Global disorders of sex development update since 2006: perceptions, approach and care. Horm Res Paediatr 85: 158\u2013180.","DOI":"10.1159\/000442975"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Batista RL, Mendonca BB (2020) Integrative and analytical review of the 5-alpha-reductase type 2 deficiency worldwide. Appl Clin Genet 13: 83\u201396.","DOI":"10.2147\/TACG.S198178"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Ivarsson SA (1996) 5-alpha reductase deficient men are fertile. Eur J Pediatr 155: 425.","DOI":"10.1007\/BF01955283"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Odame I, Donaldson MD, Wallace AM, Cochran W, Smith PJ (1992) Early diagnosis and management of 5 alpha-reductase deficiency. Arch Dis Child 67: 720\u2013723.","DOI":"10.1136\/adc.67.6.720"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Charmandari E, Dattani MT, Perry LA, Hindmarsh PC, Brook CG (2001) Kinetics and effect of percutaneous administration of dihydrotestosterone in children. Horm Res 56: 177\u2013181.","DOI":"10.1159\/000048115"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Carpenter TO, Imperato-McGinley J, Boulware SD, Weiss RM, Shackleton C, et al. (1990) Variable expression of 5 alpha-reductase deficiency: presentation with male phenotype in a child of Greek origin. J Clin Endocrinol Metab 71: 318\u2013322.","DOI":"10.1210\/jcem-71-2-318"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Sasaki G, Ogata T, Ishii T, Kosaki K, Sato S, et al. (2003) Micropenis and the 5alpha-reductase-2 (SRD5A2) gene: mutation and V89L polymorphism analysis in 81 Japanese patients. J Clin Endocrinol Metab 88: 3431\u20133436.","DOI":"10.1210\/jc.2002-021415"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Sasaki G, Ishii T, Hori N, Amano N, Homma K, et al. (2019) Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5\u03b1-reductase type 2 deficiency. Endocr J 66: 837\u2013842.","DOI":"10.1507\/endocrj.EJ19-0111"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Walter KN, Kienzle FB, Frankenschmidt A, Hiort O, Wudy SA, et al. (2010) Difficulties in diagnosis and treatment of 5alpha-reductase type 2 deficiency in a newborn with 46,XY DSD. Horm Res Paediatr 74: 67\u201371.","DOI":"10.1159\/000313372"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Konishi A, Ida S, Matsui F, Etani Y, Kawai M (2021) Male assignment in 5alpha-reductase type 2 deficiency with female external genitalia. Pediatr Int 63: 592\u2013594.","DOI":"10.1111\/ped.14447"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Swerdloff RS, Wang C (1998) Dihydrotestosterone: a rationale for its use as a non-aromatizable androgen replacement therapeutic agent. Baillieres Clin Endocrinol Metab 12: 501\u2013506.","DOI":"10.1016\/S0950-351X(98)80267-X"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Eberle AJ, Sparrow JT, Keenan BS (1986) Treatment of persistent pubertal gynecomastia with dihydrotestosterone heptanoate. J Pediatr 109: 144\u2013149.","DOI":"10.1016\/S0022-3476(86)80596-0"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Price P, Wass JA, Griffin JE, Leshin M, Savage MO, et al. (1984) High dose androgen therapy in male pseudohermaphroditism due to 5 alpha-reductase deficiency and disorders of the androgen receptor. J Clin Invest 74: 1496\u20131508.","DOI":"10.1172\/JCI111563"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Ishii T, Matsuo N, Inokuchi M, Hasegawa T (2014) A cross-sectional growth reference and chart of stretched penile length for Japanese boys aged 0\u20137 years. Horm Res Paediatr 82: 388\u2013393.","DOI":"10.1159\/000368965"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Fujieda K, Matsuura N (1987) Growth and maturation in the male genitalia from birth to adolescence. II. Change of penile length. Acta Paediatr Jpn 29: 220\u2013223.","DOI":"10.1111\/j.1442-200X.1987.tb00036.x"},{"key":"18","unstructured":"18 Takeshima Y, Suzuki M, Ikegaya H, Idota N, Kawai T, et al. (2021) A cross-sectional cadaveric study of the correlation between genital organ measurements, serum testosterone, and serum prostate-specific antigen levels in Japanese male subjects. Int J Physiol Pathophysiol Pharmacol 13: 36\u201342."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Fan L, Song Y, Polak M, Li L, Ren X, et al. (2020) Clinical characteristics and genotype-phenotype correlations of 130 Chinese children in a high-homogeneity single-center cohort with 5\u03b1-reductase 2 deficiency. Mol Genet Genomic Med 8: e1431.","DOI":"10.1002\/mgg3.1431"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Ishii T, Sasaki G, Hasegawa T, Sato S, Matsuo N, et al. (2004) Testosterone enanthate therapy is effective and independent of SRD5A2 and AR gene polymorphisms in boys with micropenis. J Urol 172: 319\u2013324.","DOI":"10.1097\/01.ju.0000129005.84831.1e"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21 Makridakis NM, di Salle E, Reichardt JK (2000) Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II. Pharmacogenetics 10: 407\u2013413.","DOI":"10.1097\/00008571-200007000-00004"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Sasaki G, Nakagawa K, Hashiguchi A, Hasegawa T, Ogata T, et al. (2003) Giant seminoma in a patient with 5 alpha-reductase type 2 deficiency. J Urol 169: 1080\u20131081.","DOI":"10.1097\/01.ju.0000047621.66463.29"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Akiba K, Aso K, Hasegawa Y, Fukami M (2021) Genome analyses and androgen quantification for an infant with 5\u03b1-reductase type 2 deficiency. J Pediatr Endocrinol Metab 34: 1191\u20131195.","DOI":"10.1515\/jpem-2020-0678"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Gui B, Song Y, Su Z, Luo FH, Chen L, et al. (2019) New insights into 5\u03b1-reductase type 2 deficiency based on a multi-centre study: regional distribution and genotype-phenotype profiling of SRD5A2 in 190 Chinese patients. J Med Genet 56: 685\u2013692.","DOI":"10.1136\/jmedgenet-2018-105915"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Gao W, Bohl CE, Dalton JT (2005) Chemistry and structural biology of androgen receptor. Chem Rev 105: 3352\u20133370.","DOI":"10.1021\/cr020456u"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Wang C, Iranmanesh A, Berman N, McDonald V, Steiner B, et al. (1998) Comparative pharmacokinetics of three doses of percutaneous dihydrotestosterone gel in healthy elderly men\u2014a clinical research center study. J Clin Endocrinol Metab 83: 2749\u20132757.","DOI":"10.1210\/jc.83.8.2749"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Choi SK, Han SW, Kim DH, de Lignieres B (1993) Transdermal dihydrotestosterone therapy and its effects on patients with microphallus. J Urol 150: 657\u2013660.","DOI":"10.1016\/S0022-5347(17)35576-3"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Thigpen AE, Silver RI, Guileyardo JM, Casey ML, McConnell JD, et al. (1993) Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression. J Clin Invest 92: 903\u2013910.","DOI":"10.1172\/JCI116665"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Ogata T, Tanaka T, Kagami M (2007) Target height and target range for Japanese children: revisited. Clin Pediatr Endocrinol 16: 85\u201387.","DOI":"10.1297\/cpe.16.85"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Kuhn JM, Rieu M, Laudat MH, Forest MG, Pugeat M, et al. (1984) Effects of 10 days administration of percutaneous dihydrotestosterone on the pituitary-testicular axis in normal men. J Clin Endocrinol Metab 58: 231\u2013235.","DOI":"10.1210\/jcem-58-2-231"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Page ST, Lin DW, Mostaghel EA, Marck BT, Wright JL, et al. (2011) Dihydrotestosterone administration does not increase intraprostatic androgen concentrations or alter prostate androgen action in healthy men: a randomized-controlled trial. J Clin Endocrinol Metab 96: 430\u2013437.","DOI":"10.1210\/jc.2010-1865"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Sircili MH, e Silva FA, Costa EM, Brito VN, Arnhold IJ, et al. (2010) Long-term surgical outcome of masculinizing genitoplasty in large cohort of patients with disorders of sex development. J Urol 184: 1122\u20131127.","DOI":"10.1016\/j.juro.2010.05.022"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 O\u2019Shaughnessy PJ, Antignac JP, Le Bizec B, Morvan ML, Svechnikov K, et al. (2019) Alternative (backdoor) androgen production and masculinization in the human fetus. PLoS Biol 17: e3000002.","DOI":"10.1371\/journal.pbio.3000002"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/70\/1\/70_EJ22-0112\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:45:04Z","timestamp":1715316304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/70\/1\/70_EJ22-0112\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej22-0112","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"EJ22-0112"}}